PRODUCT NEWS: SEPTEMBER 2013
Scouting for new instrumentation, decision-support software, equipment, or diagnostic tests? It’s all in here.
Read More
Search Results for: lung cancer
Molecular Marker Predicts Patients Most Likely to Benefit Longest From Two Popular Cancer Drugs
Preliminary study needs further confirmation.
Read More
Advances in Molecular Testing
Molecular biology is continuing to revolutionize disease diagnosis. Modern molecular tests based on the detection of nucleic acids (ie, DNA and RNA) offer considerable advantages over traditional methods of pathogen detection.
Read More
National Cancer Institute Extends Insight Genetics’ Contract to Develop Lung Cancer Diagnostic
The new, nearly $1.5 million contract with further the development of a panel of assays designed to provide a fast and accurate way to identify and characterize biomarkers estimated to constitute up to 9% of NSCLC cases.
Read More
bioTheranostics’ CancerTYPE ID Molecular Test Gets Positive Coverage Decision, In-Network Provider Status from Tufts Health Plan
The company is working with payors nationwide to make this test available to clinicians and cancer patients.
Read More